Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9000503rdf:typepubmed:Citationlld:pubmed
pubmed-article:9000503lifeskim:mentionsumls-concept:C0087140lld:lifeskim
pubmed-article:9000503pubmed:issue1lld:pubmed
pubmed-article:9000503pubmed:dateCreated1997-2-11lld:pubmed
pubmed-article:9000503pubmed:abstractTextThe c-fos proto-oncogene was discovered by homology to transforming viral genes, leading to speculation that transforming viruses had captured a cellular gene involved in cell cycle control. Indeed overexpression of c-Fos protein led to deregulated growth control, and c-Fos was thought to be so critically involved in cell cycle control that transcriptional transrepression of its own promoter was interpreted as a negative feedback mechanism. However, recent findings render this conclusion improbable, Fos transrepression being most parsimoniously explained as transcriptional squelching imposed by artificially elevated levels of exogenous Fos protein.lld:pubmed
pubmed-article:9000503pubmed:languageenglld:pubmed
pubmed-article:9000503pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000503pubmed:citationSubsetIMlld:pubmed
pubmed-article:9000503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9000503pubmed:statusMEDLINElld:pubmed
pubmed-article:9000503pubmed:monthJanlld:pubmed
pubmed-article:9000503pubmed:issn0014-5793lld:pubmed
pubmed-article:9000503pubmed:authorpubmed-author:CahillM AMAlld:pubmed
pubmed-article:9000503pubmed:issnTypePrintlld:pubmed
pubmed-article:9000503pubmed:day2lld:pubmed
pubmed-article:9000503pubmed:volume400lld:pubmed
pubmed-article:9000503pubmed:ownerNLMlld:pubmed
pubmed-article:9000503pubmed:authorsCompleteYlld:pubmed
pubmed-article:9000503pubmed:pagination9-10lld:pubmed
pubmed-article:9000503pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:meshHeadingpubmed-meshheading:9000503-...lld:pubmed
pubmed-article:9000503pubmed:year1997lld:pubmed
pubmed-article:9000503pubmed:articleTitlec-Fos transrepression revisited.lld:pubmed
pubmed-article:9000503pubmed:affiliationTranscriptional Regulation Group, Division of Immunology and Cell Biology, The John Curtin School of Medical Research, Australian National University, Canberra. Mike.Cahill@anu.edu.aulld:pubmed
pubmed-article:9000503pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9000503lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9000503lld:pubmed